• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

替莫西林（BRL 17421）的体外活性，一种新型的β-内酰胺酶稳定青霉素。

In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.

作者信息

Verbist L

出版信息

Antimicrob Agents Chemother. 1982 Jul;22(1):157-61. doi: 10.1128/AAC.22.1.157.

DOI:10.1128/AAC.22.1.157
PMID:6982023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC183693/
Abstract

The new in vitro activity of temocillin (BRL 17421), a new beta-lactamase-stable penicillin, was compared with those of other beta-lactam antibiotics for over 500 clinical bacterial isolates. Temocillin inhibited 94% of the Enterobacteriaceae organisms at concentrations of 0.5 to 8 microgram/ml, regardless of organisms resistance to ampicillin, ticarcillin, cefazolin, or combinations thereof. Most pseudomonas aeruginosa isolates and all staphylococci and streptococci tested were resistant to temocillin.

摘要

新型β-内酰胺酶稳定青霉素替莫西林（BRL 17421）的体外新活性与其他β-内酰胺类抗生素针对500多株临床分离细菌进行了比较。替莫西林在浓度为0.5至8微克/毫升时可抑制94%的肠杆菌科细菌，无论这些细菌对氨苄西林、替卡西林、头孢唑林或其组合是否耐药。大多数铜绿假单胞菌分离株以及所有测试的葡萄球菌和链球菌对替莫西林耐药。

相似文献

1
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.替莫西林（BRL 17421）的体外活性，一种新型的β-内酰胺酶稳定青霉素。
Antimicrob Agents Chemother. 1982 Jul;22(1):157-61. doi: 10.1128/AAC.22.1.157.
2
Antibacterial activity and beta-lactamase stability of temocillin.替莫西林的抗菌活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Sep;22(3):453-60. doi: 10.1128/AAC.22.3.453.
3
Comparative in-vitro activity of temocillin (BRL 17421), a new penicillin.新型青霉素替莫西林（BRL 17421）的体外活性比较
J Antimicrob Chemother. 1983 Apr;11(4):319-24. doi: 10.1093/jac/11.4.319.
4
Temocillin. In vitro activity compared with other antibiotics.
Drugs. 1985;29 Suppl 5:91-7. doi: 10.2165/00003495-198500295-00018.
5
In vitro activity of BRL 36650, a new penicillin.新型青霉素BRL 36650的体外活性
Antimicrob Agents Chemother. 1986 Feb;29(2):362-6. doi: 10.1128/AAC.29.2.362.
6
In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
J Antimicrob Chemother. 1986 Sep;18(3):351-8. doi: 10.1093/jac/18.3.351.
7
In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria.替莫西林的体外活性，一种对肠杆菌有活性的新型β-内酰胺酶稳定青霉素。
Antimicrob Agents Chemother. 1982 Aug;22(2):198-200. doi: 10.1128/AAC.22.2.198.
8
Influence of the α-Methoxy Group on the Reaction of Temocillin with Pseudomonas aeruginosa PBP3 and CTX-M-14 β-Lactamase.α-甲氧基对替莫西林与铜绿假单胞菌 PBP3 和 CTX-M-14 β-内酰胺酶反应的影响。
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.01473-19.
9
The activity of temocillin against Enterobacteriaceae, Pseudomonas and Haemophilus influenzae.
Drugs. 1985;29 Suppl 5:85-90. doi: 10.2165/00003495-198500295-00017.
10
In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.新型β-内酰胺抗生素替莫西林（BRL 17421）的体外活性
Antimicrob Agents Chemother. 1982 Oct;22(4):535-40. doi: 10.1128/AAC.22.4.535.

引用本文的文献

1
Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli.肠杆菌属体外替莫西林耐药性中双组分系统 EnvZ/OmpR 和 BaeS/BaeR 的意义。
J Antimicrob Chemother. 2024 Mar 1;79(3):641-647. doi: 10.1093/jac/dkae021.
2
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.替莫西林：作为一种潜在的碳青霉烯类替代抗生素在抗菌药物管理中的应用。
Antibiotics (Basel). 2022 Apr 7;11(4):493. doi: 10.3390/antibiotics11040493.
3
A DNA aptamer reveals an allosteric site for inhibition in metallo-β-lactamases.一种 DNA 适体揭示了金属β-内酰胺酶的别构抑制位点。
PLoS One. 2019 Apr 22;14(4):e0214440. doi: 10.1371/journal.pone.0214440. eCollection 2019.
4
Pharmacokinetics and Pharmacodynamics of Temocillin.替莫西林的药代动力学和药效学。
Clin Pharmacokinet. 2018 Mar;57(3):287-296. doi: 10.1007/s40262-017-0584-7.
5
Effect of temocillin in combination with other beta-lactam antibiotics.替莫西林与其他β-内酰胺类抗生素联合使用的效果。
Antimicrob Agents Chemother. 1984 Jan;25(1):142-4. doi: 10.1128/AAC.25.1.142.
6
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
7
Susceptibilities of 45 clinical isolates of Proteus penneri.45株彭氏变形杆菌临床分离株的药敏情况。
Antimicrob Agents Chemother. 1984 Sep;26(3):419-20. doi: 10.1128/AAC.26.3.419.
8
In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.替莫西林与替卡西林及氨基糖苷类药物对革兰氏阴性菌和革兰氏阳性菌的体外联合效应。
Drugs. 1985;29 Suppl 5:74-7. doi: 10.2165/00003495-198500295-00015.
9
A study of the penetration of temocillin in the cerebrospinal fluid.替莫西林在脑脊液中渗透性的研究。
Drugs. 1985;29 Suppl 5:162-6. doi: 10.2165/00003495-198500295-00033.
10
Renal clearance of temocillin in volunteers.
Drugs. 1985;29 Suppl 5:128-34. doi: 10.2165/00003495-198500295-00027.

本文引用的文献

1
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.GR - 20263：一种对假单胞菌属和肠杆菌科具有高活性的新型氨基噻唑基头孢菌素。
Antimicrob Agents Chemother. 1980 May;17(5):807-12. doi: 10.1128/AAC.17.5.807.
2
BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.BRL 17421是一种新型β-内酰胺抗生素，对β-内酰胺酶具有高度抗性，在人体内可产生高且持久的血清浓度。
Antimicrob Agents Chemother. 1981 Jul;20(1):38-46. doi: 10.1128/AAC.20.1.38.